drugset / Trial / NCT00668616

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

NCT00668616

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether a treatment with 4 cycles anthracycline + cyclophoshamide followed by administration of 4 cycles paclitaxel is more effective than therapy with 4 cy\<cles of anthracycline adminbistration followed by 4 cycles of paclitaxel

Timeline

Start
2000-03
Primary completion
2005-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclophosphamide Other / unclassified 600 mg/m2 Intravenous
Comparator Epirubicin Small molecule 90 mg/m2 Intravenous
Comparator Epirubicin Small molecule 120 mg/m2 Intravenous
Comparator Paclitaxel Small molecule 175 mg/m2 Intravenous
Background filgrastim Protein / enzyme biologic 5 ug/kg Subcutaneous